Reply to correspondence on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study"
- PMID: 38768963
- PMCID: PMC11540348
- DOI: 10.3350/cmh.2024.0360
Reply to correspondence on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study"
Keywords: Cardimetabolic; Ethnic; MASLD.
Conflict of interest statement
The authors have no conflicts to disclose.
Similar articles
-
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study.Clin Mol Hepatol. 2024 Apr;30(2):225-234. doi: 10.3350/cmh.2023.0515. Epub 2024 Jan 24. Clin Mol Hepatol. 2024. PMID: 38263684 Free PMC article.
-
Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences.Clin Mol Hepatol. 2024 Apr;30(2):168-170. doi: 10.3350/cmh.2024.0140. Epub 2024 Mar 5. Clin Mol Hepatol. 2024. PMID: 38439189 Free PMC article. No abstract available.
-
Correspondence on Letter regarding "Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study".Clin Mol Hepatol. 2024 Apr;30(2):281-283. doi: 10.3350/cmh.2024.0214. Epub 2024 Apr 1. Clin Mol Hepatol. 2024. PMID: 38606425 Free PMC article. No abstract available.
-
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD.Curr Obes Rep. 2024 Sep;13(3):510-531. doi: 10.1007/s13679-024-00574-z. Epub 2024 May 29. Curr Obes Rep. 2024. PMID: 38809396 Free PMC article. Review.
-
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue.J Clin Med. 2024 Jun 30;13(13):3871. doi: 10.3390/jcm13133871. J Clin Med. 2024. PMID: 38999436 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources